Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
Year: 2025
Type: article
Study design: Clinical Trial
Source: European Urology
Authors: Ruben Raychaudhuri, Ali Raza Khaki, Mary W. Redman, Kelsey K. Baker, Kevin Ng, Xueyan Chen, Jenny Mao, Brianna Woo, Aaron Lin, Andrii Hannochka, Nathan Conrad, Martha Kahugu, Patrick Panlasigui, Michael C. Haffner, Andrew C. Hsieh, Hung-Ming Lam, Funda Vakar-Lopez, Todd Yezefski, Michael T. Schweizer, Robert B. Montgomery, Evan Y. Yu, Atreya Dash, Sarah P. Psutka, Daniel W. Lin, George R. Schade, John L. Gore, Jonathan L. Wright, Petros Grivas
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W4413039830